SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to push the limits in their field and address the complex analytical challenges they face. The company’s global leadership and world-class service and support in the mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensic and clinical research.
With over 20 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis.
Our broad portfolio of scientific analytical tools include innovative instrument systems, intuitive software, pre-packaged methods and chemistry reagents -- all of which are part of workflows that reduce complexity and accelerate results. These tools apply mass spectrometry technologies to enable scientists to conduct quantitative and qualitative analysis across a wide range of applications.
We have a long history of developing first-of-its-kind products, demonstrating our ability to continue innovating for the scientific community: Supporting these tools are our services, which are among the most comprehensive for the markets we serve.
SCIEX Instruments are for Research Use Only. Not for use in diagnostic procedures. The trademarks mentioned herein are the property of SCIEX Pte Ltd or their respective owners. SCIEX™ is being used under license.
The Cancer Institute NSW is Australia's first statewide cancer control agency, established in 2003 to lessen the impact of cancer across the state of New South Wales. We are proud to support the Children's Medical Research Institute to host the 2015 Chemical Proteomics Symposium.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $17 billion and approximately 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support.
10 Years of Transforming Science
For 10 years you've never stood still. Neither have we. Celebrate 10 years of Orbitrap MS with us and look ahead to a future full of possibilities and new discoveries. Learn how scientists and researchers are solving some of today's toughest analytical challenges using our innovative contributions to the mass spectrometry community.
For those of you who cannot make ASMS, an overview will be presented post-ASMS at the Wednesday Morning Workshop and Friday Morning Breakfast Session, on the 15th and 17thof July respectively, as part of the 2015 Chemical Proteomics Symposium.
Bruker continues to expand on its comprehensive range of innovative mass spectrometry systems. The new compact, impact II™, and maXis II™ ESI–QTOF Instant Expertise™ mass spectrometers are the showcase instrument platforms for life science research, drug discovery & development, and screening applications involving the analysis of unknown compounds in complex matrices. The systems provide cutting edge performance in one-shot analysis for identification and quantitation from small molecules up to antibodies.
Visit our booth for more information on these new ESI-QTOF mass spectrometers, as well as information on the new rapifleX MALDI Tissuetyper, solariX XR FTMS, amaZon speed ETD Ion Trap MS, ultrafleXtreme MALDI TOF/TOF MS, and MALDI Biotyper.
Cell Signaling Technology (CST) has developed a proprietary proteomic method, PTMScan Technology, that overcomes the problem that many PTMs exist at very low levels. Using immunoaffinity enrichment to isolate specific modifications of interest from a protease-digested cell or tissue extract. PTMScan Technology utilizes the specificity of motif antibodies to remove a majority of the contaminating endogenous peptides and enable identification of thousands of post-translationally modified peptides of interest by LCMS techniques.
Genesearch is CST's Australian distributor and is proud to sponsor the CMRI Proteomics Symposium. We look forward to hearing the latest advances in this important area and supporting researchers interested in CST PTMScan technology.
Since 1958, Waters has been in the business of making innovative liquid chromatography and mass spectrometry products that assist scientists to invent new and more effective ways to treat diseases, reach their scientific goals, increase productivity, and earn laboratory-based organisations a higher return on their investments in research, development, and quality control.
GE Healthcare provides expertise and tools for a wide range of applications, including basic research, drug discovery research, as well as tools to support large-scale manufacturing of biopharmaceuticals. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
Equipment funding proudly supported by: